Cargando…

Prescribing pre-exposure prophylaxis for HIV

Co-formulated tenofovir disoproxil plus emtricitabine is highly effective as pre-exposure prophylaxis for HIV It is suitable for men who have sex with men, for heterosexual sex and for people who use intravenous drugs when there is a risk of HIV infection Pre-exposure prophylaxis is one pill per day...

Descripción completa

Detalles Bibliográficos
Autor principal: Bloch, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: NPS MedicineWise 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7738695/
https://www.ncbi.nlm.nih.gov/pubmed/33363302
http://dx.doi.org/10.18773/austprescr.2020.057
_version_ 1783623174721634304
author Bloch, Mark
author_facet Bloch, Mark
author_sort Bloch, Mark
collection PubMed
description Co-formulated tenofovir disoproxil plus emtricitabine is highly effective as pre-exposure prophylaxis for HIV It is suitable for men who have sex with men, for heterosexual sex and for people who use intravenous drugs when there is a risk of HIV infection Pre-exposure prophylaxis is one pill per day and can be prescribed by all medical practitioners and nurse practitioners via the Pharmaceutical Benefits Scheme. It is best prescribed in a three-monthly program with regular monitoring for patient adherence, safety, HIV and other sexually transmitted infections Prophylaxis is well tolerated but requires monitoring for kidney toxicity and low bone density
format Online
Article
Text
id pubmed-7738695
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher NPS MedicineWise
record_format MEDLINE/PubMed
spelling pubmed-77386952020-12-23 Prescribing pre-exposure prophylaxis for HIV Bloch, Mark Aust Prescr Article Co-formulated tenofovir disoproxil plus emtricitabine is highly effective as pre-exposure prophylaxis for HIV It is suitable for men who have sex with men, for heterosexual sex and for people who use intravenous drugs when there is a risk of HIV infection Pre-exposure prophylaxis is one pill per day and can be prescribed by all medical practitioners and nurse practitioners via the Pharmaceutical Benefits Scheme. It is best prescribed in a three-monthly program with regular monitoring for patient adherence, safety, HIV and other sexually transmitted infections Prophylaxis is well tolerated but requires monitoring for kidney toxicity and low bone density NPS MedicineWise 2020-12-01 2020-12 /pmc/articles/PMC7738695/ /pubmed/33363302 http://dx.doi.org/10.18773/austprescr.2020.057 Text en (c) NPS MedicineWise http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (CC BY-NC-ND) 4.0 License.
spellingShingle Article
Bloch, Mark
Prescribing pre-exposure prophylaxis for HIV
title Prescribing pre-exposure prophylaxis for HIV
title_full Prescribing pre-exposure prophylaxis for HIV
title_fullStr Prescribing pre-exposure prophylaxis for HIV
title_full_unstemmed Prescribing pre-exposure prophylaxis for HIV
title_short Prescribing pre-exposure prophylaxis for HIV
title_sort prescribing pre-exposure prophylaxis for hiv
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7738695/
https://www.ncbi.nlm.nih.gov/pubmed/33363302
http://dx.doi.org/10.18773/austprescr.2020.057
work_keys_str_mv AT blochmark prescribingpreexposureprophylaxisforhiv